We are live on
!
Find out more
EPIX
ESSA Pharma
EPIX
EPIX
Delisted
EPIX was delisted on the 8th of October, 2025.
21 hedge funds and large institutions have $76.1M invested in ESSA Pharma in 2019 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
500% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 1
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
86% more capital invested
Capital invested by funds: $41M → $76.1M (+$35.1M)
31% more funds holding
Funds holding: 16 → 21 (+5)
16.38% less ownership
Funds ownership: 83.48% → 67.1% (-16%)
50% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 2
Holders
21
Holders Change
+5
Holders Change %
+31.25%
% of All Funds
0.41%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.04%
New
6
Increased
1
Reduced
2
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Renaissance Technologies
New York
|
+$59.6K |
| 2 |
Commonwealth Equity Services
Waltham,
Massachusetts
|
+$44.3K |
| 3 |
AG
Advisor Group
Phoenix,
Arizona
|
+$39.5K |
| 4 |
Morgan Stanley
New York
|
+$35.3K |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$7.29K |
Top Sellers
| 1 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$1.81K |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
-$516 |
